NCT00145236View on ClinicalTrials.gov

Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

August 31, 2003

Conditions
Hypertension
Interventions
DRUG

Nebivolol

Trial Locations (1)

26505

Mylan Pharmaceuticals Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY